Predicting asparaginase-associated pancreatitis

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 634-639

  Knoderer, Holly M ^a   Robarge, Jason ^a   Flockhart, David A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E. coli asparaginase; Erwinia asparaginase; Pancreatitis; PEG asparaginase

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BORTEZOMIB; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOFOS; ETOPOSIDE; FLUDARABINE; GEMCITABINE; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; IFOSFAMIDE; INTERLEUKIN 2; MACROGOL; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; TENIPOSIDE; TIOGUANINE; TOPOTECAN; ASPARAGINASE MACROGOL; MACROGOL DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER; CHILDHOOD LEUKEMIA; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG FORMULATION; DRUG MEGADOSE; ESCHERICHIA COLI; HUMAN; MONOTHERAPY; NONHODGKIN LYMPHOMA; PANCREATITIS; PECTOBACTERIUM CHRYSANTHEMI; PRIORITY JOURNAL; REPEATED DRUG DOSE; SYSTEMATIC REVIEW; CHEMICALLY INDUCED DISORDER; CHILD; DRUG SCREENING; FEMALE; INCIDENCE; INFANT; MALE; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; DEXAMETHASONE; DRUG EVALUATION; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PANCREATITIS; POLYETHYLENE GLYCOLS; PREDICTIVE VALUE OF TESTS; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 35148891622     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21037     Document Type: Article

References (37)

1. Avramis V, Spencer S, Periclou A, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children's Cancer Group study. Blood 2001;99:1986-1994.
2. Duval M, Suciu S, Ferster A, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: Results of a randomized European Organization for Research and Treatment of Cancer - Children's Leukemia Group phase 3 trial. Blood 2002;99:2734-2739.
3. Silverman L, Gelber R, Dalton V, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana Farber Consortium Protocol 91-01. Blood 2001;97:1211-1218.
4. Balis F, Holcenberg JB, Blaney SM. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins; 2002. 1692p.
5. Ettinger L, Kurtzberg J, Voute P, et al. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Cancer 1995;75:1176-1181.
6. Muller H, Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 1998;28:97-113.
7. Broome J. Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme of asparagine levels in the blood, normal tissues and 6C3HED lymphoma of mice: Differences in asparaginase formulation and utilization in asparaginase-sensitive and-resistant lymphoma cells. J Exp Med 1968;127: 1055-1072.
8. McLean R, Martin S, Lam-Po-Tang P. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982;2:1401-1402.
9. Sahu S, Saika S, Pai S, et al. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1998;15:533-538.
10. Weetman R, Baehner R. Latent onset of clinical pancreatitis in children receiving L'asparaginase therapy. Cancer 1974;34: 780-785.
11. Land V, Sutow W, Fernbach D, et al. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972;30:339-347.
12. Greenstein R, Nogeire C, Ohnuma T, et al. Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst. Cancer 1979;43:718-722.
13. Tan C, Chiang S, Wee K. Acute hemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukemia - A case report. Singapore Med J 1974;15:278-282.
14. Shaw M, Barnes CM, Shaw FJ, et al. L-asparaginase and pancreatitis. Lancet 1970;721:p. 721.
15. Jain R, Ramanan S. Iatrogenic pancreatitis: A fatal complication in the induction therapy for acute lymphoblastic leukemia. Arch Intern Med 1978;138:1726.
16. Alvarez O, Zimmerman G. Pegasparaginase-induced pancreatitis. Med Pediatr Oncol 2000;24:200-205.
17. Bertolone S, Fuenfer M, Groff D, et al. Delayed pancreatic pseudocyst formation - Long term complication of L'asparaginase therapy. Cancer 1982;50:2964-2966.
18. Murakawa M, Okamura T, Shibuya T, et al. Use of a synthetic protease inhibitor for the treatment of L-asparaginase induced acute pancreatitis complicated by disseminated intravascular coagulation. Ann Hematol 1992;64:249-252.
19. Tiao M, Chuang J, Ko S, et al. Pancreatitis in children: Clinical analysis of 61 cases in southern Taiwan. Chang Gung Med J 2002; 25:162-168.
20. Charan VD, Xxx N, Singh A, et al. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy. Indian Pediatr 1993;30:809-810.
21. Chen C, Lu M, Lin K, et al. Ureteral obstruction caused by L-asparaginase-induced pancreatitis in a child with acute lymphoblastic leukemia. J Formos Med Assoc 2004;103:380-384.
22. Cheung Y, Lee C, Chan C, et al. Somatostatin therapy in L-asparaginase-induced pancreatitis. Med Pediatr Oncol 1994;22: 421-424.
23. Garrington T, Bensard D, Ingram J, et al. Successful management with octreotide of a child with L-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol 1998;30:106-109.
24. Hsu Y, Chen Y, Ho C, et al. Diabetic ketoacidosis and persistent hyperglycemia as long-term complications of L-asparaginase-induced pancreatitis. Chin Med J 2002;65:441-445.
25. Lamelas R, Chapchap P, Magalhaes A, et al. Successful management of a child with asparaginase-induced hemorrhagic pancreatitis. Med Pediatr Oncol 1999;32:316.
26. Nakamura C, Wilkinson R, Woodruff K. Pancreatitis and parotitis following therapy with asparaginase. Int Pediatr 1999;14:25-27.
27. Top B, Tissing W, Kuiper J, et al. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Pediatr Blood Cancer 2005;44:95-97.
28. Yang C, Hsieh Y, Hwang B. Acute pancreatitis in association with L-asparaginase therapy: Report of one case. Chin Med J 1993;51: 74-77.
29. Yu C, Lin K, Lin D, et al. L-asparaginase-related pancreatic pseudocyst: Report of a case. J Formos Med Assoc 1994;93:441-444.
30. Winter S, Holdsworth M, Devidas M, et al. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: A report of POG study 9296. Pediatr Blood Cancer 2006;46:179-186.
31. Agrawal N, Bukowski R, Rybicki L, et al. A phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma. Cancer 2003;98:94-99.
32. Eden O, Shaw M, Lilleyman J, et al. Non-randomized study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukemia. Med Pediatr Oncol 1990;18:497-502.
33. Trivedi C, Pitchumoni C. Drug-induced pancreatitis: An update. J Clin Gastroenterology 2005;39:709-716.
34. Siemers R, Friedenberg W, Norfleet R. High-dose cytarabine arabinoside-associated pancreatitis. Cancer 1985;56:1940-1942.
35. Runzi M, Layer P. Drug-associated pancreatitis: Facts and fiction. Pancreas 1996;13:100-109.
36. Weaver G. Steroid-induced pancreatitis. Gastroenterology 1982; 82:601-603.
37. Jackson W. Pancreatitis: Etiology, diagnosis, and management. Curr Opin Pediatr 2001;13:447-451.